ZEVRA THERAPEUTICS, INC. Quarterly Interest Expense in USD from Q1 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Zevra Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2014 to Q1 2024.
  • Zevra Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $735K, a 304% increase year-over-year.
  • Zevra Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $2.05M, a 301% increase year-over-year.
  • Zevra Therapeutics, Inc. annual Interest Expense for 2023 was $1.5M, a 348% increase from 2022.
  • Zevra Therapeutics, Inc. annual Interest Expense for 2022 was $335K, a 48.2% increase from 2021.
  • Zevra Therapeutics, Inc. annual Interest Expense for 2021 was $226K, a 95.3% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.05M $735K +$553K +304% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.5M $756K +$586K +345% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $915K $366K +$242K +195% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $673K $197K +$161K +447% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $512K $182K +$177K +3540% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $335K $170K +$165K +3300% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $170K $124K +$118K +1967% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $52K $36K +$20K +125% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $32K $5K -$194K -97.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $226K $5K -$1.16M -99.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 $1.39M $6K -$1.16M -99.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $2.54M $16K -$1.18M -98.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $3.72M $199K -$1.06M -84.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $4.79M $1.17M -$24K -2.02% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $4.81M $1.16M -$45K -3.73% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $4.85M $1.2M -$35K -2.84% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $4.89M $1.26M +$31K +2.52% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $4.86M $1.19M -$52K -4.19% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 $4.91M $1.21M -$159K -11.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 $5.07M $1.23M -$187K -13.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $5.26M $1.23M -$213K -14.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $5.47M $1.24M -$203K -14.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 $5.67M $1.37M -$81K -5.59% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $5.75M $1.42M -$24K -1.66% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $5.78M $1.44M +$1K +0.07% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $5.78M $1.44M -$1K -0.07% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-30
Q3 2017 $5.78M $1.45M +$7K +0.49% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $5.77M $1.44M -$32K -2.17% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $5.8M $1.44M +$291K +25.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $5.51M $1.45M +$747K +107% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-30
Q3 2016 $4.76M $1.44M +$754K +110% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-30
Q2 2016 $4.01M $1.48M +$821K +126% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-30
Q1 2016 $3.19M $1.15M +$518K +82% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-30
Q4 2015 $2.67M $698K +$67K +10.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 $2.6M $687K +$514K +297% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-10
Q2 2015 $2.09M $654K -$50K -7.1% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-10
Q1 2015 $2.14M $632K +$536K +558% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-10
Q4 2014 $1.6M $631K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-16
Q3 2014 $173K Jul 1, 2014 Sep 30, 2014 10-K 2016-03-16
Q2 2014 $704K Apr 1, 2014 Jun 30, 2014 10-K 2016-03-16
Q1 2014 $96K Jan 1, 2014 Mar 31, 2014 10-K 2016-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.